Interestingly, while administration of GEP12 did not result in a reduction in GLP-1R internalization, when evaluated in the presence of a Y1-R antagonist, it elicited increased insulin secretion in rat islets compared to results obtained with either GEP44 or Ex-4
nAMD Symptoms May Include: Distortion of straight lines (metamorphopsia) Blurred or fuzzy central vision Dark or empty areas in the center of vision Difficulty seeing fine detail, even with glasses Sudden worsening of visual acuity The aggressive nature of nAMD means early detection plays a key role in preventing permanent vision loss
Sabatine MS, Giugliano RP, Keech AC, et al
Symptoms of gastroparesis often include: Severe, persistent nausea Repetitive and uncontrollable vomiting, sometimes of food eaten hours or days before A feeling of fullness after eating very little Abdominal bloating and severe pain Acid reflux or heartburn Significant weight loss and malnutrition Dehydration due to persistent vomiting A diagnosis of gastroparesis can be devastating
The drug works by mimicking the effects of GLP-1 and hitting receptors for another hormone, GIP, which leads to even more weight loss
Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice
